blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1064262

EP1064262 - SUBSTITUTED ISOINDOLONES AND THEIR USE AS CYCLIC GMP MODULATORS IN MEDICAMENTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.12.2003
Database last updated on 06.07.2024
Most recent event   Tooltip23.12.2016Lapse of the patent in a contracting statepublished on 25.01.2017  [2017/04]
Applicant(s)For all designated states
Aventis Pharma Deutschland GmbH
65929 Frankfurt am Main / DE
[2001/01]
Inventor(s)01 / SCHINDLER, Ursula
Robert-Stolz-Strasse 56
D-65812 Bad Soden / DE
02 / SCHÖNAFINGER, Karl
Holunderweg 8
D-63755 Alzenau / DE
03 / STROBEL, Hartmut
Erlenweg 22
D-65835 Liederbach / DE
04 / GROEHN, Viola
Hardstrasse 10
CH-8212 Neuhausen / CH
[2001/01]
Application number, filing date99907548.412.02.1999
[2001/01]
WO1999EP00931
Priority number, dateDE199810742321.02.1998         Original published format: DE 19807423
[2001/01]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO9942444
Date:26.08.1999
Language:DE
[1999/34]
Type: A1 Application with search report 
No.:EP1064262
Date:03.01.2001
Language:DE
The application published by WIPO in one of the EPO official languages on 26.08.1999 takes the place of the publication of the European patent application.
[2001/01]
Type: B1 Patent specification 
No.:EP1064262
Date:12.02.2003
Language:DE
[2003/07]
Search report(s)International search report - published on:EP26.08.1999
ClassificationIPC:C07D209/48, A61K31/40, C07D401/04, C07D409/04
[2001/01]
CPC:
C07D209/48 (EP,US); A61P1/16 (EP); A61P11/06 (EP);
A61P13/12 (EP); A61P15/10 (EP); A61P25/28 (EP);
A61P3/10 (EP); A61P43/00 (EP); A61P7/02 (EP);
A61P9/00 (EP); A61P9/02 (EP); A61P9/10 (EP);
A61P9/12 (EP); C07D401/04 (EP,US); C07D409/04 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [2001/01]
TitleGerman:SUBSTITUIERTE ISOINDOLONE UND IHRE VERWENDUNG ALS CYCLISCHE GMP MODULATOREN IN ARZNEIMITTELN[2001/01]
English:SUBSTITUTED ISOINDOLONES AND THEIR USE AS CYCLIC GMP MODULATORS IN MEDICAMENTS[2001/01]
French:ISOINDOLONES SUBSTITUEES ET LEUR UTILISATION COMME MODULATEURS DU GMP CYCLIQUE[2001/01]
Entry into regional phase21.09.2000National basic fee paid 
21.09.2000Designation fee(s) paid 
21.09.2000Examination fee paid 
Examination procedure25.08.1999Request for preliminary examination filed
International Preliminary Examining Authority: EP
21.09.2000Examination requested  [2001/01]
18.06.2002Despatch of communication of intention to grant (Approval: Yes)
28.08.2002Communication of intention to grant the patent
09.12.2002Fee for grant paid
09.12.2002Fee for publishing/printing paid
Opposition(s)13.11.2003No opposition filed within time limit [2004/06]
Fees paidRenewal fee
28.02.2001Renewal fee patent year 03
28.02.2002Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DA]EP0667345  (YUNG SHIN PHARM IND CO LTD [TW]) [DA] 1,12 * page 3 *;
 [A]EP0743304  (MERCK PATENT GMBH [DE]) [A] 1,12* claims 1,9 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.